Salt la conţinut

Obstetrică

Managementul şi optimizarea hemostazei

Agenți antifibrinolitici

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (se deschide o fereastră nouă)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Sursă‎: Lancet 2018;391(10116):125-32.

Index‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (se deschide o fereastră nouă)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (se deschide o fereastră nouă)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Sursă‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Index‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (se deschide o fereastră nouă)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (se deschide o fereastră nouă)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Sursă‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Index‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (se deschide o fereastră nouă)

Factorul VII (rFVIIa) recombinant activat

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (se deschide o fereastră nouă)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Sursă‎: Obstet Gynecol 2007;110(6):1270-8.

Index‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (se deschide o fereastră nouă)

The use of recombinant activated FVII in postpartum hemorrhage. (se deschide o fereastră nouă)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Sursă‎: Clin Obstet Gynecol 2010;53(1):219-27.

Index‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (se deschide o fereastră nouă)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (se deschide o fereastră nouă)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Sursă‎: J Perinat Med 2011;40(1):43-9.

Index‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (se deschide o fereastră nouă)

Postpartum hemorrhage: when uterotonics and sutures fail. (se deschide o fereastră nouă)

James AH, McLintock C, Lockhart E.

Sursă‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Index‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (se deschide o fereastră nouă)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (se deschide o fereastră nouă)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Sursă‎: J Thromb Haemost 2015;13(4):520-9.

Index‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (se deschide o fereastră nouă)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (se deschide o fereastră nouă)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Sursă‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Index‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (se deschide o fereastră nouă)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (se deschide o fereastră nouă)

Pepas LP, Arif-Adib M, Kadir RA.

Sursă‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Index‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (se deschide o fereastră nouă)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (se deschide o fereastră nouă)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Sursă‎: Anesth Analg 2009;109(6):1908-15.

Index‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (se deschide o fereastră nouă)

Concentrați din factori de coagulare

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (se deschide o fereastră nouă)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Sursă‎: Transfus Med 2012;22(5):344-9.

Index‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (se deschide o fereastră nouă)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (se deschide o fereastră nouă)

Bell SF, Rayment R, Collins PW, Collis RE.

Sursă‎: Int J Obstet Anesth 2010;19(2):218-23.

Index‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (se deschide o fereastră nouă)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (se deschide o fereastră nouă)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Sursă‎: Br J Anaesth 2012;108(6):984-9.

Index‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (se deschide o fereastră nouă)

Desmopresină

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (se deschide o fereastră nouă)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Sursă‎: Haemophilia 2012;18(1):25-33.

Index‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (se deschide o fereastră nouă)

Agenți hemostatici topici

Tisseel for management of traumatic postpartum haemorrhage. (se deschide o fereastră nouă)

Dhulkotia JS, Alazzam M, Galimberti A.

Sursă‎: Arch Gynecol Obstet 2009;279(3):437-9.

Index‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (se deschide o fereastră nouă)

Uterine packing with chitosan-covered tamponade to treat postpartum hemorrhage. (se deschide o fereastră nouă)

Henrich W, Dückelmann A, Braun T, Hinkson L

Sursă‎: Am J Obstet Gynecol 2024;230(3S):S1061-65.

Index‎: PubMed 38462249

DOI‎: 10.1016/j.ajog.2022.11.1297

https://pubmed.ncbi.nlm.nih.gov/38462249/ (se deschide o fereastră nouă)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (se deschide o fereastră nouă)

Moriarty KT, Premila S, Bulmer PJ.

Sursă‎: BJOG 2008;115(6):793-5.

Index‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (se deschide o fereastră nouă)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (se deschide o fereastră nouă)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Sursă‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Index‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (se deschide o fereastră nouă)

Fibrin sealant for management of complicated obstetric lacerations. (se deschide o fereastră nouă)

Whiteside JL, Asif RB, Novello RJ.

Sursă‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Index‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (se deschide o fereastră nouă)

Teste vâscoelastice pentru identificarea sângerării chirurgicale sau coagulopatice